Current status of cediranib: the rapid development of a novel anti-angiogenic therapy

Author： Lindsay Colin R   MacPherson Iain RJ   Cassidy Jim  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.5, Iss.4, 2009-05, pp. : 421-432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-angiogenic therapy for osteosarcoma

By Quan Gerald  

Cancer and Metastasis Reviews, Vol. 25, Iss. 4, 2006-12 ,pp. : 707-713

Springer Publishing Company

Access to resources Recommend Favorite

Anti-angiogenic Therapy in Pediatric Neuro-oncology

By Kieran Mark  

Journal of Neuro-Oncology, Vol. 75, Iss. 3, 2005-12 ,pp. : 327-334

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Angiogenic Therapy as a Cancer Treatment Paradigm

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 115-130

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic Therapy in Renal Cell Carcinoma

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 77-83

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 1, 2015-01 ,pp. : 37-47

Bentham Science Publishers

Access to resources Recommend Favorite